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Cardiovascular systemThe medial amygdaloid nucleus (MeA) is involved in cardiovascular control. In the present study we report the
effect of MeA pharmacological ablations caused by bilateral microinjections of the nonselective synaptic blocker
CoCl2 on cardiac baroreﬂex responses in rats. MeA synaptic inhibition evoked by local bilateral microinjection of
100 nL of CoCl2 (1mM) did not affect blood pressure or heart rate baseline, suggesting no tonicMeA inﬂuence on
resting cardiovascular parameters. However, 10min after CoCl2 microinjection into theMeA of maleWistar rats,
the reﬂex bradycardic response evoked by intravenous infusion of phenylephrine was signiﬁcantly enhanced
when compared with the reﬂex bradycardic response observed before CoCl2. The treatment did not affect the
tachycardic responses to the intravenous infusion of sodium nitroprusside (SNP). Baroreﬂex activity returned
to control values 60 min after CoCl2 microinjections, conﬁrming a reversible blockade. The present results indi-
cate an involvement of theMeA in baroreﬂexmodulation, suggesting that synapses in theMeAhave an inhibitory
inﬂuence on the bradycardic component of the baroreﬂex in conscious rats.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
The amygdaloid complex is a limbic structure associated with auto-
nomic, neuroendocrine and behavioral responses (Fortaleza et al., 2011;
Ma andMorilak, 2005; Price et al., 1987; Sah et al., 2003) that is located
in the temporal lobe between the external capsule and the hypothala-
mus. Based on its cytoarchitecture and chemoarchitecture, it has been
divided into subnuclei having extensive internuclear and intranuclear
connections (Krettek and Price, 1978b; Price et al., 1987). The amygda-
loid complex is divided into three groups: (1) the deep or basolateral
group, which includes the lateral, basal and the accessory basal nucleus;
(2) the superﬁcial or cortical-like group, which includes the cortical
nucleus and the nucleus of the lateral olfactory tract; and (3) the
centromedial group, composed by the medial and central nuclei
(Pitkanen et al., 1997; Sah et al., 2003).
Among the amygdaloid complex nuclei, the medial amygdaloid nu-
cleus (MeA) is involved in cardiovascular control and modulates stress
responses (Fortaleza et al., 2009, 2011, 2012b; Gelsema et al., 1987;
Kubo et al., 2004; Morilak et al., 2005).
Electrical stimulation of the MeA has been reported to evoke mean
arterial pressure (MAP) and heart rate (HR) increases in anesthetized
rats (Faiers et al., 1975). In addition, we have previously shown that.microinjection of noradrenaline into the MeA caused cardiovascular
changes, and that stress-evoked heart rate increases are modulated by
different types of adrenoceptors in the MeA (Fortaleza et al., 2011,
2012b), suggesting its involvement in central cardiovascular control.
Baroreceptor activity provides an essential feedback to the central
nervous system (CNS) formoment-to-moment control of the cardiovas-
cular function, in order to maintain arterial pressure within a narrow
functional range (Michelini, 1994; Sved and Gordon, 1994). Moreover,
it has been proposed that a resetting of baroreﬂex activity towards
higher blood pressure values mediates, at least in part, autonomic and
cardiovascular changes during physical exercise and stress situations
(Crestani et al., 2010b; Dampney et al., 2008; DiCarlo and Bishop,
1992). Defensive reactions are associated with changes in cardiovascu-
lar activity. Cardiovascular changes include increases in MAP, HR, sym-
pathetic nerve activity and skeletal muscle blood ﬂow (Coote et al.,
1979). These simultaneous enhancements inMAP, HR, and sympathetic
vasomotor activity imply in a reset of the baroreceptor reﬂex (Coote
et al., 1979; Hatton et al., 1997; Hilton and Zbrozyna, 1963; Nunomura
et al., 1983; Porter, 2000; Schlor et al., 1984; Turnbull et al., 1993).
The MeA is connected with medullary structures that appear to be
the primary site involved in baroreﬂex responses (Dampney, 1994;
Krettek and Price, 1978a; Michelini, 1994; Schreihofer and Guyenet,
2002; Sved andGordon, 1994).Moreover, it sends projections to several
limbic structures that are involved in baroreﬂexmodulation, such as the
medial prefrontal cortex (Resstel and Correa, 2006; Sevoz-Couche et al.,
2006), the bed nucleus of the stria terminalis (Crestani et al., 2006), the
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(Crestani et al., 2010a; Sevoz-Couche et al., 2006), lateral septal area
(Scopinho et al., 2007, 2012) and the diagonal band of Broca (Crestani
et al., 2008b).
There is functional evidence showing a possible MeA involvement
in the basal control of baroreﬂex activity, resulting from power
spectral analysis that evaluates variability of the HR and MAP (Neckel
et al., 2012; Quagliotto et al., 2008), or in BPH/2J mice, a neuro-
genic model of hypertension, in which theMeAwas proposed to partic-
ipate in cardiac baroreﬂex sensitivity control (Jackson et al., 2014),
consequently it would be relevant to evaluate the role of MeA in the
modulation on baroreﬂex activity response evoked by intravenous infu-
sion of phenylephrine (Phe) or sodiumnitroprusside (SNP) in conscious
rats.
The hypothesis of the present study is that the MeA is involved in
baroreﬂex modulation in conscious rats. To investigate this hypothesis,
we analyzed the effect of the blockade of synaptic transmission in the
MeA, caused by local microinjection of CoCl2 that reduces pre-synaptic
Ca2+ inﬂux leading to inhibition of neurotransmitter release, on the
cardiac baroreﬂex response evokedby the intravenous infusion of either
Phe or SNP.2. Material and methods
2.1. Animal preparation
Twenty male Wistar rats weighing 230–270 g were used. Animals
were kept in the Animal Care Unit of the Department of Pharmacology,
School of Medicine of Ribeirão Preto, University of São Paulo. Rats were
housed individually in plastic cages under standard laboratory condi-
tions; a 12 h light–dark cycle, and free access to food andwater. Housing
conditions and experimental procedures were approved by the
Institution's Animal Ethical Committee (Proc 128/2010).
Four days before experiments, rats were anesthetized with tri-
bromoethanol (250mg/kg i.p.). After scalp anesthesiawith 2% lidocaine,
the skull was exposed and stainless steel guide cannulas (26G)
were stereotaxically implanted bilaterally into the MeA. Coordinates
for cannula implantation into the MeA were: AP = +6.2 mm; L =
+3.4 mm from the medial suture and V = −8.8 mm, based on
the rat brain atlas of Paxinos and Watson (1997). One day before
the experiment, rats were anesthetized with tribromoethanol and a
catheter was inserted into the abdominal aorta through the femoral
artery for MAP and HR recording. A second catheter was implanted
into the femoral vein for infusion of either phenylephrine or SNP.
Catheters were tunneled under the skin and exteriorized on the
animal's dorsum.2.2. Measurement of cardiovascular responses
Experimentswere carried out between 08:00–12:00 h. On the day of
the experiment, animals were allowed a 15 min period to adapt to ex-
perimental room's conditions, such as sound and illumination, before
starting blood pressure and HR recording. Another 15 min period was
allowed before beginning the experiments. The room was acoustically
isolated and had constant backgroundnoise provided by an air exhaust-
er. Care was taken to start injections when stable blood pressure and
specially heart rate recordings were observed. The injection needle
was slowly introduced into the guide cannula without touching or
restraining the animals. Pulsatile arterial pressure of freely moving ani-
mals was recorded using an HP-7754A preampliﬁer (Hewlett Packard,
Palo Alto, Califórnia, USA) and an acquisition board (MP100A, Biopac
Systems Inc, Santa Barbara, Califórnia, USA) connected to a computer.
MAP and HR values were derived from the blood pressure recordings
and processed online.2.3. Drug injection
Drugs were dissolved in artiﬁcial cerebrospinal ﬂuid (aCSF) with the
following composition: NaCl 100 mM; Na3PO4 2 mM; KCl 2,5 mM;
MgCl2 1,0 mM; NaHCO3 27 mM; CaCl2 2,5 mM (pH = 7.4). Needles
(33G, Small Parts, Miami Lakes, Flórida, USA) that were used for micro-
injection into theMeAwere 1mm longer than guide cannulas andwere
connected to a 1 μL syringe (7002H, Hamilton, USA) through PE-10 tub-
ing. CoCl2 or vehiclewas injected in a ﬁnal volume of 100 nL in each side
of the MeA. After a 20 s period, the needle was removed and inserted
into the second guide cannula for microinjections into the contralateral
side.
2.4. Baroreﬂex stimulation
Baroreﬂex was activated by intravenous infusion of phenylephrine
(Phe, 50 μg/kg; 0.34 mL/min) or SNP (50 μg/kg; 0.8 mL/min), using an
infusion pump (K.D. Scientiﬁc, Holliston, Massachusetts, USA).
2.5. Method of baroreﬂex evaluation
HR values matchingMAP variations were determined. Paired values
of MAP andHR variations, evoked by Phe or SNP, were plotted to gener-
ate sigmoid curves (Head & McCarty, 1987) for each rat, which were
used to determine baroreﬂex activity. Commercial software (Prism,
Prism, GraphPad, San Diego, California, USA) was used to generate
curves.
To study bradycardic and tachycardic responses separately, HR
values matching 10, 20, 30 and 40 mmHgMAP changes were calculat-
ed. Values were plotted to create linear regression curves for each rat
(Crestani et al., 2006; Resstel et al., 2004) and their slopes were com-
pared to verify changes in baroreﬂex gain. The delay in reﬂex bradycar-
dia and tachycardia was about 1.2 s because of the time of baroreﬂex
synapse processing that is 700 ms according to Su et al. (1992) and
the integration factor of the recording system that was about 500 ms.
2.6. Drugs
The following drugs were used: phenylephrine-HCl; CoCl2 (Sigma,
St. Louis, Missouri, USA); sodium nitroprusside; urethane (Sigma, St
Louis, Missouri, USA) and tribromoethanol (Aldrich, St Louis, Missouri,
USA).
2.7. Experimental protocols
All animals used in this study received three infusions of either
phenylephrine or SNP to determine control baroreﬂex response. One
group received bilateral microinjections of aCSF into the MeA and infu-
sions of phenylephrine or sodium nitroprusside were repeated 10 min
after this procedure. A second group received bilateral microinjections
of CoCl2 (1 mM; Crestani et al., 2006) into the MeA, and phenylephrine
or nitroprusside infusions were repeated 10 and 60 min after injection.
A third group received bilateral microinjections of CoCl2 (1 mM) into
structures surrounding theMeA, and phenylephrine or nitroprusside in-
fusionswere repeated 10min after injection. The order of infusionswas
randomized. CoCl2 interferes with synaptic Ca2+ and consequently
causes nonspeciﬁc synaptic blockade. Its effectiveness is accepted as in-
dicative of synaptic involvement (Kretz, 1984).
2.8. Histological procedure
At the end of the experiments, rats were anesthetizedwith urethane
(1.25 g/kg, i.p.) and 100 nL of 1% Evan's blue dyewas bilaterally injected
into the MeA to label injection sites. The chest was surgically opened,
the descending aorta occluded, the right atrium severed and the brain
perfused with 10% formalin through the left heart ventricle. Brains
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cryostat (CM-1900, Leica, Germany). Sections were stained with 1%
cresyl violet and injection sites were identiﬁed.
2.9. Statistical analysis
Baseline cardiovascular values before and after CoCl2 or aCSF were
compared using the Student's t test. Baroreﬂex was analyzed using sig-
moid curves that were characterized by 4 parameters: (i) P1 (bpm)
lower HR plateau and P2 (bpm) upper plateau; (ii) HR range (bpm),
i.e. difference between upper and lower plateau levels; (iii) median
blood pressure (BP50, mm Hg) which is the MAP at 50% of the HR
range; and (iv) average gain (G, bpm/mm Hg) which is the average
slope of the curves (Korner et al., 1972; Head & McCarty, 1987). Signif-
icant differences between sigmoid curves or linear regressions parame-
ters to CoCl2 microinjection into theMeAwere analyzed using one-way
ANOVA followed by the Dunnett's test. Signiﬁcant differences between
sigmoid curve and linear regressions parameters to aCSFmicroinjection
into the MeA or CoCl2 microinjection into structures surrounding the
MeA were analyzed using the Student's t test. It was assumed P b 0.05
as signiﬁcant.
3. Results
Fig. 1 shows a representative photomicrograph of aMeA coronal sec-
tion and Fig. 2 shows a diagrammatic representation, according
(Paxinos andWatson, 1997) of the all microinjection sites from experi-
mental groups.
3.1. Effect of bilateral microinjections of aCSF into theMeA on the baroreﬂex
response to intravenous infusion of phenylephrine or sodium nitroprusside
in conscious rats
Bilateral microinjections of 100 nL of aCSF (n= 7) into the MeA did
not affect MAP (97 ± 5 vs 99 ± 4 mm Hg, t = 0.05, P N 0.05) or HR
(340 ± 11 vs 345 ± 12 bpm, t= 0.03, P N 0.05) baseline.
Nonlinear and linear regression analysis of baroreﬂex activity indi-
cated that microinjections of aCSF into the MeA did not affect the baro-
reﬂex response (Fig. 3). The nonlinear regression analysis indicated that
aCSF had no effect on the baroreﬂex parameters analyzed in the sigmoid
curve (Fig. 3 and Table 1). Moreover, linear regression also indicated no
differences in the slope of bradycardic (−1.70 ± 0.22 vs−1.59 ± 0.20
bpm/mm Hg, t = 0.3, P N 0.05) or tachycardic (−1.66 ± 0.18 vs
−1.84 ± 0.11 bpm/mm Hg, t= 0.9, P N 0.05) responses after aCSF mi-
croinjection into the MeA (Fig. 3).Fig. 1. Photomicrograph of a coronal brain section from one representative rat, showing
the microinjection site in the medial amygdaloid nucleus (MeA).3.2. Effect of bilateral microinjections of CoCl2 (1mM) in the structures sur-
rounding the MeA on the baroreﬂex response to intravenous infusion of
phenylephrine or sodium nitroprusside in conscious rats
Bilateral microinjections of 100 nL of 1 mM CoCl2 (n = 5) in
structures surrounding the MeA did not affect MAP (97 ± 5 vs 100 ±
7 mm Hg, t = 0.08, P N 0.05) or HR (353 ± 10 vs 358 ± 13 bpm, t =
0.08, P N 0.05) baseline.
Nonlinear and linear regression analysis of baroreﬂex activity indi-
cated that microinjections of 1 mM CoCl2 in structures surrounding
theMeA (n=5) did not affect the baroreﬂex response (Fig. 4). The non-
linear regression analysis indicated that the 1mMCoCl2 had no effect on
the baroreﬂex parameters analyzed in the sigmoid curve (Fig. 4 and
Table 1). Moreover, the linear regression also indicated there are no
differences in the slope of bradycardic (−1.91 ± 0.13 vs −1.64 ±
0.23 bpm/mm Hg, t = 0.8, P N 0.05) or tachycardic (−1.72 ± 0.20 vs
−1.91 ± 0.10 bpm/mm Hg, t = 0.8, P N 0.05) responses after 1 mM
CoCl2 in structures surrounding the MeA (Fig. 4).
3.3. Effect of bilateral microinjections of CoCl2 (1 mM) into the MeA on the
baroreﬂex response to intravenous infusion of phenylephrine or sodium ni-
troprusside in conscious rats
Bilateral microinjections of 100 nL of 1 mM CoCl2 (n = 7) into the
MeA did not affect MAP (99 ± 4 vs 101 ± 5 mmHg, t = 0.09,
P N 0.05) or HR (348± 12 vs 354± 10 bpm, t=0.07, P N 0.05) baseline.
Nonlinear and linear regression analysis of baroreﬂex activity indi-
cated that microinjection of 1 mM CoCl2 into the MeA altered the baro-
reﬂex response (Fig. 5). The nonlinear regression analysis indicated that
1 mM CoCl2 into the MeA only increased the curve slope (Fig. 5 and
Table 1). Moreover, linear regression indicated that the slope of the
bradycardic (−1.21 ± 0.23 vs −1.95 ± 0.20 bpm/mm Hg, F(2,20) =
3.66, P b 0.05) response was increased after microinjection of 1 mM
CoCl2 into the MeA, but the tachycardic (−2.31 ± 0.30 vs −2.04 ±
0.35 bpm/mm Hg, F(2,20) = 0.19, P N 0.05) response was not altered
after MeA blockade (Fig. 5). The recovery of baroreﬂex to control levels
was observed 60 min after the administration of 1 mM CoCl2 into the
MeA (bradycardia:−1.32 ± 0.20; P N 0.05 and tachycardia:−2.17 ±
0.27; P N 0.05) (Fig. 5). A representative recording showing the increase
in bradycardic component caused by the microinjection of CoCl2 into
the MeA is presented in Fig. 6.
4. Discussion
The acute and reversible pharmacological inhibition of theMeAneu-
rotransmission by local microinjection of CoCl2 enhanced the baroreﬂex
bradycardic response, suggesting that local synapses are involved in the
modulation of the parasympathetic component of cardiac baroreﬂex in
conscious rats. The pretreatment with CoCl2 reduces Ca2+ pre-synaptic
inﬂux leading to an inhibition of neurotransmitters release and conse-
quent synaptic blockade (Kretz, 1984). Therefore, our results suggest
that such inhibitory inﬂuence of MeA on the baroreﬂex involves local
synapses and not an inhibition of passing ﬁbers.
Analysis of sigmoid curves generated 10 min after CoCl2 microinjec-
tion into the MeA indicated a signiﬁcant increase in the magnitude of
the reﬂex bradycardia caused by the intravenous infusion of phenyleph-
rine, without effect on the tachycardic response to intravenous infusion
of SNP. These data suggest that MeA has an inhibitory role on cardiac
baroreﬂex in rats. Moreover, CoCl2 microinjection did not affect BP
and HR baselines; a result in accordance with previous reports from
our laboratory showing no signiﬁcant contribution of the MeA in the
baseline cardiovascular control (Fortaleza et al., 2009).
Analysis of the baroreﬂex sigmoid curve showed that bilateral micro-
injection of CoCl2 into the MeA only increased the slope of the sigmoid
curve (G parameter). None of the other parameters analyzed in the sig-
moid curve were affected by the treatment with CoCl2, i.e. the lower HR
Fig. 2.Diagrammatic representation based on the rat brain atlas of Paxinos andWatson (1997) indicating injection sites of aCSF (white circles, n= 7) or CoCl2 (black circles, n= 7) in the
MeA, and injection sites of CoCl2 in surrounding areas (gray circles, n = 5). ic—internal capsula, ot—optical tract, IA—Interaural coordinate, CeA—central amygdaloid nucleus,
BLA—basolateral amygdaloid nucleus.
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and lower HR plateaus) and BP50. The baroreﬂex response returned to
control values 60 min after CoCl2 administration, indicating reversibilityFig. 3. A) Sigmoid baroreﬂex curves correlating mean arterial pressure (ΔMAP) and heart rate
brospinalﬂuid (aCSF) into theMeA. B) Linear regression baroreﬂex curves correlatingmean arte
r2 = 0.78 to bradycardic) or after microinjection of aCSF in the MeA (r2 = 0.86 to tachycardicof the synaptic inhibition caused by CoCl2. The present results suggest
that reversible inhibition of the MeA neurotransmission with CoCl2 only
enhances the bradycardic component of the baroreﬂex activity in rats.responses (Δ HR) before (r2 = 0.87) or after (r2 = 0.92) microinjection of artiﬁcial cere-
rial pressure (ΔMAP) and heart rate responses (ΔHR) before (r2=0.78 to tachycardic and
and r2 = 0.85 to bradycardic).
Table 1
Parameters derived from the sigmoidal curve generated before and after bilateralmicroinjection of aCSF (n=7), 1mM cobalt into structures surrounding theMeA (n=5) or 1mMcobalt
into the MeA (n = 7).
G (bpm/mm Hg) P1 (bpm) P2 (bpm) Range (bpm)
aCSF t= 0.40 t= 0.08 t= 0.44 t= 0.18
Before −1.10 ± 0.14 −59 ± 7 70 ± 4 129 ± 8
10 min after −1.19 ± 0.08 −59 ± 4 67 ± 4 127 ± 7
Cobalt surrounding MeA t= 0.03 t= 0.57 t= 0.38 t= 0.60
Before −1.38 ± 0.12 −67 ± 3 70 ± 6 137 ± 8
10 min after −1.37 ± 0.09 −63 ± 4 68 ± 4 131 ± 2
Cobalt into the MeA F(2.20) = 57.29 F(2.20) = 2.51 F(2.20) = 0.03 F(2.20) = 1.16
Before −0.95 ± 0.07 −42 ± 8 76 ± 9 118 ± 14
10 min after −1.88 ± 0.07* −66 ± 10 75 ± 11 141 ± 12
60 min after −1.01 ± 0.06 −44 ± 7 73 ± 8 118 ± 11
Values are means ± SEM. Student's t test was used to compare the values before and after microinjection of aCSF or 1 mM cobalt into structures surrounding the MeA. One-way ANOVA
followed by Dunnett's post-test was used to compare the values before, 10 min and 60 min after microinjection of 1 mM cobalt into the MeA. *P b 0.05, signiﬁcant difference from values
before and after 1 mM cobalt into the MeA. Slope of the sigmoid curve gain (G); lower HR plateau (P1); upper HR plateau (P2).
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responsewas analyzed using linear regression analysis. Linear regression
analysis indicated that acute inhibition of the MeA neurotransmission
enhanced the bradycardic response to MAP increases caused by intrave-
nous infusion of phenylephrine, conﬁrming the hypothesis that theMeA
plays an inhibitory role on the cardiac parasympathetic baroreﬂex mod-
ulation. Evidence from power spectral analysis carried out in genetically
hypertensive BPH/2Jmice indicates that permanent lesion of theMeA in-
creases baroreﬂex gain due to vagal contribution (Jackson et al., 2014).
Although the present result from the use of CoCl2 points to the MeA
as part of the neural brain pathwaymodulating the bradycardic compo-
nent of baroreﬂex, the putative neurotransmitters are not known, and
will demand further studies to be identiﬁed. Glutamate and GABA are
widespread as neurotransmitters in the CNS, and may be considered
as putative mediators involved in baroreﬂexmodulation. In the bed nu-
cleus of the stria terminalis (BST), the blockade of glutamatergic NMDA
receptors increased the gain of the parasympathetic component of the
baroreﬂex (Alves et al., 2009a), indicating an inhibitory role of the glu-
tamatergic transmission on the parasympathetic component of the
baroreﬂex. The microinjection of glutamate and GABA into the
posterodorsalMeA of conscious rats, in a volume of 300 nL, has been re-
ported to decreasemaximumbaroreﬂex gain (Neckel et al., 2012), indi-
cating that activation of local glutamatergic and gabaergic receptors
could involved in the mediation of the inhibitory role of the MeA on
the parasympathetic component of the baroreﬂex presently evidenced.
The MeA noradrenergic neurotransmission should also be considered
as a possible candidate to baroreﬂexmodulator. In the BST, the blockade
of α1-adrenoceptors increased the gain of the parasympatheticFig. 4. A) Sigmoid baroreﬂex curves correlating mean arterial pressure (ΔMAP) and heart rat
surrounding theMeA (r2= 0.96). B) Linear regression curves for baroreﬂex, correlating mean a
and r2 = 0.87 to bradycardic) or after microinjection of CoCl2 in structures surrounding the Mcomponent of the baroreﬂex (Crestani et al., 2008a), also indicating an
inhibitory role of the local BST noradrenergic transmission on the para-
sympathetic component of the baroreﬂex.We have previously reported
that microinjection of noradrenaline into the MeA evoked pressor and
bradycardic responses through acute vasopressin release into circula-
tion (Fortaleza et al., 2011). Vasopressin-mediated cardiovascular re-
sponses following noradrenaline microinjection into the MeA are
mediated by activation of local α2-adrenoceptors and magnocellular
neurons in the paraventricular and supraoptic nuclei (Fortaleza et al.,
2011, 2012a). However, the observation that the magnitude of the
bradycardic response evoked by noradrenaline in this area signiﬁcantly
correlates with themagnitude of the pressor response favors the idea of
a reﬂex mechanism. The involvement of the noradrenergic neurotrans-
mission from several brain regions of the central nervous system in the
control of baroreﬂex response has been well documented (Alves et al.,
2009b; Crestani et al., 2008a; Hwang et al., 1998; Scopinho et al.,
2012). Thismodulation could either be due to inhibition of baroreceptor
input to vagal neurons or to facilitation of an inhibitory drive to these
neurons, thus enhancing parasympathetic response to blood pressure
increase. Alternatively, the bradycardic response caused by activation
of noradrenergic receptors could be due to a direct inﬂuence of the
MeA onvagal activity, without interferencewith baroreﬂexmodulation.
Further experiments are necessary to clarify this issue. Although central
glutamatergic, gabaergic, and noradrenergic pathways seem to play a
role in baroreﬂex activity, its involvement in baroreﬂex modulation by
the MeA yet has to be evaluated.
There is evidence showing that dense neuronal connections be-
tween the MeA and brainstem and supramedullary areas such as thee responses (Δ HR) before (r2 = 0.92) or after the microinjection of CoCl2 into structures
rterial pressure (ΔMAP) and heart rate responses (ΔHR) before (r2= 0.76 to tachycardic
eA (r2 = 0.95 to tachycardic and r2 = 0.87 to bradycardic).
Fig. 5. A) Sigmoid baroreﬂex curves correlating mean arterial pressure increase (ΔMAP) and heart rate response (Δ HR) before (r2 = 0.82), 10 min (r2 = 0.83) or 60 min (r2 = 0.82)
after bilateral microinjection of 1 mM of CoCl2 into the MeA (n = 7). B) Linear regression curve correlating mean arterial pressure increase (ΔMAP) and bradycardic response (Δ HR)
before (r2 = 0.70), 10 min (r2 = 0.58) or 60 min (r2 = 0.68) after bilateral microinjection of 1 mM of CoCl2 into the MeA. Linear regression curve correlating mean arterial pressure de-
crease (ΔMAP) and tachycardic response (Δ HR) before (r2 = 0.52), 10 min (r2 = 0.63) or 60 min (r2 = 0.60) after bilateral microinjection of 1 mM of CoCl2 into the MeA (*) P b 0.05,
signiﬁcantly different between sigmoid curves or linear regressions parameters CoCl2 and aCSF, one-way ANOVA.
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2012a; Ohta et al., 1991). The role ofmedullary structures in the barore-
ﬂex is well documented (Michelini, 2007; Spyer, 1981; Sved and
Gordon, 1994). In addition, the BST is a functionally heterogenous com-
ponent of the extended amygdala that has been implicated in inhibitory
actions on the cardiac baroreﬂex parasympathetic component, as well
as in the modulation of cardiovascular responses during stressful situa-
tions (Crestani et al., 2006, 2007). It has been reported that the MeA
modulates autonomic responses to stressful stimuli (Canteras et al.,
1995; Chen and Herbert, 1995; Cullinan et al., 1995; Dayas et al.,
2001a; Fortaleza et al., 2012b; Fortaleza et al., 2009; Kubo et al., 2004),
and that the baroreﬂex parasympathetic component is suppressed dur-
ing stress (Nosaka, 1996). Therefore, we suggest that the MeA could be
modulating the baroreﬂex parasympathetic component during defen-
sive situations.
Baroreﬂex inhibition was also reported to involve other areas of the
limbic system, such as the dorsolateral periaqueductal gray matter
(Nosaka et al., 1993; Pelosi et al., 2007), the medial prefrontal cortex
(Resstel and Correa, 2006; Resstel et al., 2004), lateral septal area
(Scopinho et al., 2007, 2012) and the diagonal band of Broca (Crestani
et al., 2008b). These areas are connected to the MeA (Bienkowski
et al., 2013; Canteras et al., 1995), suggesting the existence of an inter-
relation between them in baroreﬂex modulation under aversive condi-
tions. Moreover, the MeA plays an inhibitory role on the cardiac
component of restraint-evoked cardiovascular responses in rats
(Fortaleza et al., 2009). These results support the idea that the MeAFig. 6. Recordings of one CoCl2-treated animal illustrating the bradycardic reﬂex in re-
sponse to blood pressure increase caused by intravenous phenylephrine infusion before
and 10 min after the bilateral microinjection of CoCl2 (1 mM) into the MeA.can modulate the baroreﬂex cardiac component during stress
situations.
In summary, the present results showing that acute synaptic inhibi-
tion of theMeA, caused by themicroinjection of CoCl2, enhanced cardiac
baroreﬂex bradycardic responses suggest that local synapses in that
area are involved in the modulation of bradycardic reﬂex magnitude
in response to MAP increases caused by phenylephrine infusion, sug-
gesting a tonic inhibitory role of the MeA on the bradycardic baroreﬂex
component. Results also indicate thatMeA inhibition does not affect the
tachycardic baroreﬂex response to MAP decreases, in normotensive
conscious rats.
5. Conclusions
The microinjection of CoCl2 into MeA enhanced cardiac baroreﬂex
bradycardic responses suggest that local synapses in that area are in-
volved in the modulation of bradycardic reﬂex magnitude in response
to MAP increases caused by phenylephrine infusion, suggesting a tonic
inhibitory role of the MeA on the bradycardic baroreﬂex component.
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